Columns: 1: chrom, 2: pos, 3: ref, 4: alt, 5: start, 6: stop, 7: strand, 8: variation_type, 9: variation_id, 10: rcv, 11: scv, 12: allele_id, 13: symbol, 14: hgvs_c, 15: hgvs_p, 16: molecular_consequence, 17: clinical_significance, 18: clinical_significance_ordered, 19: pathogenic, 20: likely_pathogenic, 21: uncertain_significance, 22: likely_benign, 23: benign, 24: review_status, 25: review_status_ordered, 26: last_evaluated, 27: all_submitters, 28: submitters_ordered, 29: all_traits, 30: all_pmids, 31: inheritance_modes, 32: age_of_onset, 33: prevalence, 34: disease_mechanism, 35: origin, 36: xrefs, 37: dates_ordered, 38: gold_stars, 39: conflicted,
================
Total rows: 287641
================
column 8: variation_type
Variant      287640
Haplotype         1
Name: variation_type, dtype: int64
================
column 17: clinical_significance
Uncertain significance                                                           116097
Likely benign                                                                     50903
Pathogenic                                                                        43470
Benign                                                                            23267
Likely pathogenic                                                                 14026
Conflicting interpretations of pathogenicity                                      12322
Benign/Likely benign                                                              10671
not provided                                                                      10669
Pathogenic/Likely pathogenic                                                       2950
other                                                                              1790
risk factor                                                                         395
drug response                                                                       261
association                                                                         126
Affects                                                                              95
Pathogenic, other                                                                    90
Pathogenic, risk factor                                                              78
Conflicting interpretations of pathogenicity, risk factor                            45
protective                                                                           26
Pathogenic, drug response                                                            26
Benign, risk factor                                                                  26
Likely pathogenic, risk factor                                                       24
Benign/Likely benign, risk factor                                                    22
Likely benign, risk factor                                                           22
Benign, other                                                                        22
Uncertain significance, risk factor                                                  19
Pathogenic/Likely pathogenic, risk factor                                            19
Uncertain significance, drug response                                                16
Conflicting interpretations of pathogenicity, other                                  13
Likely pathogenic, drug response                                                     11
Benign/Likely benign, not provided                                                    9
                                                                                  ...  
Likely benign, protective                                                             2
Conflicting interpretations of pathogenicity, association, other, risk factor         2
Benign/Likely benign, Affects                                                         2
Likely pathogenic, association                                                        2
Conflicting interpretations of pathogenicity, protective                              2
Pathogenic, other, protective                                                         2
Likely benign, association                                                            2
Benign, drug response, risk factor                                                    1
Benign, protective, risk factor                                                       1
Pathogenic, association, protective                                                   1
Pathogenic/Likely pathogenic, Affects, risk factor                                    1
Conflicting interpretations of pathogenicity, Affects, association, other             1
Uncertain significance, association                                                   1
Benign, drug response                                                                 1
Benign/Likely benign, protective, risk factor                                         1
Likely benign, drug response                                                          1
Benign, association, protective                                                       1
Likely benign, Affects                                                                1
Benign/Likely benign, drug response                                                   1
Conflicting interpretations of pathogenicity, other, risk factor                      1
Benign/Likely benign, drug response, risk factor                                      1
Uncertain significance, Affects                                                       1
Pathogenic/Likely pathogenic, not provided                                            1
Likely pathogenic, Affects                                                            1
Benign, association, risk factor                                                      1
Affects, risk factor                                                                  1
Benign, Affects                                                                       1
Pathogenic, protective, risk factor                                                   1
Uncertain significance, protective                                                    1
Conflicting interpretations of pathogenicity, Affects, other                          1
Name: clinical_significance, dtype: int64
================
column 24: review_status
criteria provided, single submitter                     189611
criteria provided, multiple submitters, no conflicts     33970
no assertion criteria provided                           32386
criteria provided, conflicting interpretations           12278
no assertion provided                                    10666
reviewed by expert panel                                  8599
no assertion for the individual variant                    106
practice guideline                                          23
-                                                            2
Name: review_status, dtype: int64
================
column 38: gold_stars
1    181037
0     37970
2     30274
1     20852
3      5592
0      5188
2      3696
3      3007
4        23
-         2
Name: gold_stars, dtype: int64
================
column 27: all_submitters
Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                                                              75365
GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      37902
Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     19654
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics                                                                                                                                                                                                                                                                                                                                                                                                                                       14777
OMIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        14318
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine                                                                                                                                                                                                                                                                                                                                                                                                                  8872
Ambry Genetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                               8108
PreventionGenetics,PreventionGenetics                                                                                                                                                                                                                                                                                                                                                                                                                                                        4969
Genetic Services Laboratory, University of Chicago                                                                                                                                                                                                                                                                                                                                                                                                                                           4582
GeneReviews                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2349
Counsyl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      2211
PreventionGenetics,PreventionGenetics;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                                         1966
GeneDx;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1830
Ambry Genetics;Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1584
ITMI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1497
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)                                                                                                                                                                                                                                                                                                                                                                                                            1472
Illumina Clinical Services Laboratory,Illumina;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                        1433
Invitae                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1299
Invitae;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                               1291
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                 1263
InSiGHT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1208
Tuberous sclerosis database (TSC2)                                                                                                                                                                                                                                                                                                                                                                                                                                                           1190
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                         1177
Retina International                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1057
Systems Biology Platform Zhejiang California International NanoSystems Institute                                                                                                                                                                                                                                                                                                                                                                                                             1005
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                            992
Praxis fuer Humangenetik Tuebingen,                                                                                                                                                                                                                                                                                                                                                                                                                                                           970
Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)                                                                                                                                                                                                                                                                                                                    947
GeneReviews;OMIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                              945
Ambry Genetics;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                                                                         941
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ...  
Invitae;Breast Cancer Information Core (BIC) (BRCA2);Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Counsyl;Ambry Genetics                                                                                                                                                                                                                                                                                                                                   1
GeneDx;Invitae;Division of Genomic Diagnostics,The Children's Hospital of Philadelphia                                                                                                                                                                                                                                                                                                                                                                                                          1
ARUP Institute,ARUP Laboratories;Genetic Services Laboratory, University of Chicago;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx                                                                                                                                                                                                                                                                                                                                                1
PreventionGenetics,PreventionGenetics;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Illumina Clinical Services Laboratory,Illumina;Invitae;Ambry Genetics                                                                                                                                                                                                                                                                                                                               1
PreventionGenetics,PreventionGenetics;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;ITMI;Illumina Clinical Services Laboratory,Illumina;Database of Curated Mutations (DoCM)                                                                                                                                                                                                                                                                                      1
Ambry Genetics;PreventionGenetics,PreventionGenetics;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Illumina Clinical Services Laboratory,Illumina;Invitae                                                                                                                                                                                                                                                                                                                        1
Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario;Invitae;Breast Cancer Information Core (BIC) (BRCA2)                                                                                                                                                                                                                                                                                                                                                                      1
Laboratory Corporation of America,;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;Laboratory of Genetics and Molecular Cardiology,University of São Paulo;GeneDx;Stanford Center for Inherited Cardiovascular Disease,Stanford University;Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario;Biesecker Lab/Human Development Section,National Institutes of Health;Illumina Clinical Services Laboratory,Illumina;Invitae;Ambry Genetics        1
Database of Curated Mutations (DoCM);Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;Genome Sciences Centre,British Columbia Cancer Agency                                                                                                                                                                                                                                                                                                                          1
Invitae;Breast Cancer Information Core (BIC) (BRCA1);Quest Diagnostics Nichols Institute San Juan Capistrano,;Ambry Genetics;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx                                                                                                                                                                                                                                                                                                       1
Laboratory Corporation of America,;GeneDx;Color Genomics, Inc.,                                                                                                                                                                                                                                                                                                                                                                                                                                 1
GeneReviews;OMIM;NeuroMeGen,Hospital Clinico Santiago de Compostela;Ambry Genetics;GeneDx;Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences                                                                                                                                                                                                                                                                                                   1
Department of Immunology,Hospital Universitario Virgen del Rocio;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                                 1
Biesecker Lab/Human Development Section,National Institutes of Health;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;GeneDx;Ambry Genetics;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                          1
Department of Medical Genetics,Oslo University Hospital;Quest Diagnostics Nichols Institute San Juan Capistrano,;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Sharing Clinical Reports Project (SCRP);Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;GeneDx;Ambry Genetics;Invitae                                                                                  1
Illumina Clinical Services Laboratory,Illumina;GeneReviews;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                                               1
Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Sharing Clinical Reports Project (SCRP);Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario;Invitae;Ambry Genetics;GeneKor MSA;GeneDx                                                                                                                 1
Centre for Genomic Medicine, Manchester,Central Manchester University Hospitals;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                  1
Breast Cancer Information Core (BIC) (BRCA1);Counsyl;Sharing Clinical Reports Project (SCRP);Michigan Medical Genetics Laboratories,University of Michigan;GeneDx;Genetics Diagnostic Laboratory,Children's Hospital of Eastern Ontario;Invitae;Baylor Miraca Genetics Laboratories                                                                                                                                                                                                             1
Illumina Clinical Services Laboratory,Illumina;Invitae;Breast Cancer Information Core (BIC) (BRCA2);Sharing Clinical Reports Project (SCRP);Ambry Genetics                                                                                                                                                                                                                                                                                                                                      1
Invitae;Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Sharing Clinical Reports Project (SCRP);Counsyl;GeneDx                                                                                                                                                                                                                                                                                            1
OMIM;Cardiovascular Biomedical Research Unit,Royal Brompton & Harefield NHS Foundation Trust;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;Centre for Mendelian Genomics,University Medical Centre Ljubljana                                                                                                                                                                                                                                                      1
Invitae ;Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Department of Medical Genetics,Oslo University Hospital;Quest Diagnostics Nichols Institute San Juan Capistrano,;Ambry Genetics                                                                                                                                1
GeneReviews;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Illumina Clinical Services Laboratory,Illumina                                                                                                                                                                                                                                                                                                                                                                         1
Institute of Experimental Endocrinology,Slovak Academy of Sciences                                                                                                                                                                                                                                                                                                                                                                                                                              1
Invitae;GeneDx;University of Washington Department of Laboratory Medicine,University of Washington;Quest Diagnostics Nichols Institute San Juan Capistrano,;Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA);Sharing Clinical Reports Project (SCRP);Breast Cancer Information Core (BIC) (BRCA1);Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge;Ambry Genetics;Color Genomics, Inc.,                                1
Laboratory Corporation of America,;Cardiovascular Biomedical Research Unit,Royal Brompton & Harefield NHS Foundation Trust;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;GeneDx;Invitae;Ambry Genetics                                                                                                                                                                                                                                                            1
Invitae;Ambry Genetics;CSER_CC_NCGL, University of Washington Medical Center;GeneDx                                                                                                                                                                                                                                                                                                                                                                                                             1
GeneReviews;OMIM;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;Baylor Miraca Genetics Laboratories;Genetic Services Laboratory, University of Chicago;GeneDx                                                                                                                                                                                                                                                                                                                            1
Genetic Services Laboratory, University of Chicago;Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine;EGL Genetic Diagnostics,Eurofins Clinical Diagnostics;GeneDx;Invitae                                                                                                                                                                                                                                                                                             1
Name: all_submitters, dtype: int64
================
column 31: inheritance_modes
Autosomal dominant inheritance                                                                                                59483
Autosomal recessive inheritance                                                                                               24286
Autosomal dominant inheritance;Autosomal recessive inheritance                                                                 2758
X-linked inheritance                                                                                                           2355
Autosomal dominant inheritance;Somatic mutation                                                                                1348
Autosomal recessive inheritance;Autosomal dominant inheritance                                                                  922
X-linked dominant inheritance;X-linked inheritance                                                                              516
X-linked recessive inheritance                                                                                                  484
Autosomal recessive inheritance;Mitochondrial inheritance                                                                       319
Autosomal dominant inheritance;Sporadic                                                                                         313
Somatic mutation                                                                                                                286
Autosomal dominant inheritance;Autosomal recessive inheritance;Other                                                            221
Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic                                                         217
Sporadic                                                                                                                        193
Autosomal recessive inheritance;X-linked inheritance;X-linked recessive inheritance                                             188
Autosomal recessive inheritance;X-linked inheritance                                                                            115
Autosomal recessive inheritance;Codominant                                                                                      102
X-linked inheritance;X-linked recessive inheritance                                                                             100
Autosomal dominant inheritance;X-linked dominant inheritance                                                                     96
Somatic mutation;Autosomal dominant inheritance                                                                                  91
Autosomal dominant inheritance;Autosomal unknown;Autosomal recessive inheritance                                                 91
Mitochondrial inheritance                                                                                                        78
Sporadic;Autosomal recessive inheritance;Autosomal dominant inheritance                                                          62
Autosomal recessive inheritance;Autosomal dominant inheritance;Sporadic                                                          58
Autosomal dominant inheritance;Sporadic;Autosomal recessive inheritance                                                          55
Sporadic;Autosomal dominant inheritance;Autosomal recessive inheritance                                                          52
Autosomal recessive inheritance;Sporadic;Autosomal dominant inheritance                                                          49
Autosomal dominant inheritance;X-linked inheritance                                                                              47
Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic;X-linked dominant inheritance;X-linked inheritance       32
Autosomal recessive inheritance;Autosomal dominant inheritance;Autosomal unknown                                                 30
Autosomal unknown                                                                                                                25
X-linked dominant inheritance                                                                                                    25
X-linked inheritance;Autosomal recessive inheritance                                                                             19
Sex-limited autosomal dominant;Autosomal recessive inheritance                                                                   18
X-linked dominant inheritance;X-linked recessive inheritance                                                                     17
Autosomal recessive inheritance;Sex-limited autosomal dominant                                                                   16
X-linked dominant inheritance;X-linked inheritance;Autosomal dominant inheritance;Autosomal recessive inheritance;Sporadic       16
Autosomal dominant inheritance;Autosomal unknown                                                                                 14
Sex-limited autosomal dominant                                                                                                   13
Sporadic;Autosomal dominant inheritance                                                                                           9
Autosomal dominant inheritance;Autosomal recessive inheritance;Autosomal unknown                                                  8
Other                                                                                                                             7
Autosomal dominant inheritance;Autosomal recessive inheritance;Somatic mutation                                                   4
Somatic mutation;Autosomal dominant inheritance;Autosomal recessive inheritance                                                   4
Autosomal dominant inheritance;Somatic mutation;Autosomal recessive inheritance                                                   4
X-linked inheritance;Autosomal recessive inheritance;X-linked recessive inheritance                                               3
X-linked recessive inheritance;Autosomal dominant inheritance                                                                     2
Autosomal dominant inheritance;Mitochondrial inheritance                                                                          1
Autosomal recessive inheritance;X-linked inheritance;X-linked recessive inheritance;Autosomal dominant inheritance                1
Autosomal dominant inheritance;X-linked inheritance;Autosomal recessive inheritance                                               1
Autosomal recessive inheritance;Autosomal dominant inheritance;X-linked inheritance                                               1
Somatic mutation;Autosomal dominant inheritance;Autosomal unknown                                                                 1
Somatic mutation;Sporadic;Autosomal dominant inheritance                                                                          1
Autosomal dominant inheritance;Autosomal unknown;Somatic mutation                                                                 1
Autosomal dominant inheritance;Autosomal recessive inheritance;Mitochondrial inheritance                                          1
Sporadic;Somatic mutation;Autosomal dominant inheritance                                                                          1
Autosomal recessive inheritance;Codominant;X-linked inheritance;X-linked recessive inheritance                                    1
Name: inheritance_modes, dtype: int64
================
column 32: age_of_onset
Infancy                                        22007
All ages                                       21929
Childhood                                      16102
Adult                                           7842
Adolescent                                      7637
Antenatal                                       6830
Neonatal                                        5693
Adolescent;All ages                             1856
Neonatal/infancy                                 626
Adult;Childhood                                  318
Adolescent;Childhood                             317
Infancy;Neonatal;Neonatal/infancy                309
Childhood;Adult                                  295
Childhood;Infancy                                288
Infancy;Childhood                                255
Adolescent;Infancy                               230
All ages;Childhood                               210
Infancy;Neonatal                                 188
Neonatal;Infancy                                 187
Childhood;Adolescent                             171
All ages;Neonatal                                146
Adult;All ages                                   139
Childhood;Adult;Adolescent;All ages              129
Infancy;Adolescent                               122
All ages;Adult                                   118
Adult;Infancy                                    115
Adolescent;All ages;Childhood;Adult              113
Adult;Childhood;Adolescent;All ages              109
All ages;Childhood;Neonatal                      105
Childhood;All ages                               103
                                               ...  
All ages;Childhood;Adult;Adolescent                1
Adolescent;Variable;Childhood                      1
Childhood;All ages;Adolescent;Adult                1
Antenatal;Adult;Infancy;All ages                   1
Adult;Neonatal/infancy;Infancy                     1
All ages;Childhood;Antenatal                       1
Adult;All ages;Adolescent                          1
Childhood;All ages;Adolescent                      1
Infancy;Adult;All ages                             1
Infancy;Childhood;Adolescent                       1
Infancy;Adolescent;Adult;Childhood                 1
Adult;Infancy;Childhood                            1
Childhood;Adult;Infancy                            1
Neonatal;Adolescent                                1
Antenatal;Adolescent;Neonatal/infancy              1
Adult;Adolescent;All ages;Childhood                1
Neonatal;Childhood;Infancy;Antenatal               1
Childhood;Neonatal;Infancy;Antenatal               1
Infancy;Childhood;Neonatal;Neonatal/infancy        1
Childhood;Infancy;Adult;All ages                   1
Adolescent;Adult;Childhood;Infancy                 1
Adult;Neonatal                                     1
Childhood;Infancy;Adolescent                       1
All ages;Infancy;Adolescent;Adult                  1
Adolescent;Infancy;All ages;Adult                  1
Childhood;Neonatal;Variable;All ages;Adult         1
Childhood;Infancy;Antenatal;Neonatal               1
Adult;Childhood;Infancy                            1
Antenatal;Infancy;All ages;Adult                   1
Adolescent;Adult;Childhood                         1
Name: age_of_onset, dtype: int64
================
column 33: prevalence
<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              24319
1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               18145
1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             14555
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               6618
1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 6242
1-9 / 100 000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 2148
http://www.ncbi.nlm.nih.gov/books/NBK1247/;1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1231
1 in 2000-4000 depending on the population studied.;1-9 / 100 000;1:3200                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1193
2.29 to 3.2 per 100,000 individuals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1096
http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1030
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.;http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1017
1-5 / 10 000;1:3,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          922
1-9 / 1 000 000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                579
>1 / 1000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     476
1-9 / 100 000;Prevalence in Finland is at least 9:100,000 individuals.;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         394
<1 / 1 000 000;1-9 / 100 000;Prevalence in Finland is at least 9:100,000 individuals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         387
<1 / 1 000 000;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  328
1-9 / 100 000;Rett syndrome is an X linked condition that occurs in 1 in 10,000 to 1 in 15,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   301
1-9 / 100 000;CHARGE syndrome is an autosomal dominant condition that occurs in 1 in 12,000 live births.;CHARGE syndrome occurs in at least one in 10,000 births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             292
1-9 / 100 000;CdLS occurs in 1 in 10-100,000 live births.;Cornelia de Lange syndrome occurs in 1 in 10-100,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   278
1-5 / 10 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  253
<1 / 1 000 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                252
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            251
1-9 / 100 000;Wilson disease is an autosomal recessive disorder with a prevalence of 1/30,000, and a carrier frequency of 1/90.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               233
1/15 000;1:15,000;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              232
1-9 / 1 000 000;Hennekam et al [1990b] reported a birth prevalence of 1:100,000 to 1:125,000 for RSTS in the Netherlands.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     231
1 per million;<1 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  225
1-9 / 100 000;<1 / 1 000 000;Prevalence in Finland is at least 9:100,000 individuals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         207
1-9 / 100 000;Sotos syndrome is an autosomal dominant condition that occurs in 1 in 14,000 live births.;Sotos syndrome occurs in 1 in 14,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     204
1 in 5,000 male live births;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     201
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ...  
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.;http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                    1
1-5 / 10 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1/100,000;1/100,000 births;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1
1-5 / 10 000;http://www.ncbi.nlm.nih.gov/books/NBK1247/                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         1
1-9 / 1 000 000;Gastric cancer is the 4th most frequently diagnosed cancer and the 2nd leading cause of death from cancer, with an estimated 990000 new cases and 738000 deaths registered.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
<1 / 1 000 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 100 000;1-9 / 1 000 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-9 / 100 000;1-9 / 1 000 000;1/35000;The prevalence of MEN 2 has been estimated at 1:35,000 [DeLellis et al 2004].;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1
1-9 / 1 000 000;1-9 / 100 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1
1-9 / 1 000 000;6-9 / 10 000;<1 / 1 000 000;1-9 / 100 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          1
1-9 / 1 000 000;2:100.000;2.29 to 3.2 per 100,000 individuals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.;1-9 / 1 000 000;http://www.ncbi.nlm.nih.gov/books/NBK1247/;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                    1
1-9 / 1 000 000;1-5 / 10 000;1-9 / 100 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-9 / 100 000;Rett syndrome is an X linked condition that occurs in 1 in 10,000 to 1 in 15,000 live births.;The prevalence of AS is one in 12,000-20,000 population;The prevalence of AS is one in 12,000-20,000 population.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
20210G>A heterozygosity occurs in 1.7%-3% of the general US and European populations: in the US, the prevalence of 20210G>A heterozygosity is 2%-5% in whites and 0%-0.3% in African Americans: among adults with VTE, 20210G>A heterozygosity is present in 6%-14% of those with a first VTE, and 18%-21% of those with a personal or family history of recurrent VTE: the prevalence of 20210G>A homozygosity is approximately one in 10,000. Double heterozygosity for the 20210G>A and factor V Leiden alleles occurs in approximately one in 1000 individuals in the general population and 2%-4.5% of persons with VTE;The prevalence of the G20210A in the general population is estimated to be 2.0%.     The prevalence of the G20210A substitution varies by ethnicity. It is most common in Europeans. the incidence is approximately 3.0% in southern Europeans, and 1.7% in northern Europeans. G20210A appears to be very rare in individuals of Asian and African descent.;<1 / 1 000 000        1
<1 / 1 000 000;1-9 / 1 000 000;Estimates range from 1:250,000 to 1:50,000.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      1
1-5 / 10 000;1-9 / 100 000;Hereditary breast and ovarian cancer (HBOC) resulting from mutations in BRCA1 and BRCA2 is the most common form of both hereditary breast and ovarian cancers and occurs in all ethnic and racial populations. The overall prevalence of BRCA1/2 mutations is estimated to be from 1:400 to 1:800 [Ford et al 1994, Claus et al 1996, Whittemore et al 1997], but varies depending on ethnicity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
1-9 / 1 000 000;1 in 248,000 (combined Niemann-Pick A/B)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        1
20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 100 000;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                1
1-5 / 10 000;1-9 / 100 000;6-9 / 10 000;<1 / 1 000 000;Beta-thalassemia is one of the most common autosomal recessive disorders worldwide.  10% depending on the studied population                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1
1-9 / 100 000;CHARGE syndrome is an autosomal dominant condition that occurs in 1 in 12,000 live births.;CHARGE syndrome occurs in at least one in 10,000 births.;Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1
1-5 / 10 000;1/20,000 births (in all ethnic groups);1/20,000 births in general population                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1
1-9 / 100 000;BWS is a panethnic disorder with an estimated population incidence of 1 in 13 700.;Sotos syndrome is an autosomal dominant condition that occurs in 1 in 14,000 live births.;Sotos syndrome occurs in 1 in 14,000 live births.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
1-9 / 1 000 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              1
Gastric cancer is the 4th most frequently diagnosed cancer and the 2nd leading cause of death from cancer, with an estimated 990000 new cases and 738000 deaths registered.;1-9 / 100 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1
1-9 / 100 000;1-5 / 10 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.;1-9 / 1 000 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1
1-5 / 10 000;males affected with fragile X syndrome: 16 to 25:100,000  females affected with fragile X syndrome: approximately one-half the males prevalence  Unaffected female FMR1 carriers: 1:113 to 1:259  Females with FMR1-related POF: 4%-6% of all cases of 46,XX,POI  FXTAS males: an estimated 2%-4% of men with adult-onset cerebellar ataxia who represent simplex cases have a premutation in FMR1.;males affected with fragile X syndrome: 1:2,564 to 1:6,250  females affected with fragile X syndrome: approximately one-half the males prevalence  Unaffected female FMR1 carriers: 1:113 to 1:382  Females with FMR1-related POF: 1:7 (1:15 for the general population)                                                                                                                                                                                                                                                                                                                       1
<1 / 1 000 000;1-9 / 100 000;1-5 / 10 000;20-30% HER2-positive cases for metastatic carcinomas, and only 11% of the screen-detected breast carcinomas displayed HER2/neu gene amplification.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    1
<1 / 1 000 000;The estimated incidence of permanent neonatal diabetes ranges from 1:215,000 to 1:260,000 live births                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            1
<1 / 1 000 000;1-9 / 1 000 000;1-5 / 10 000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1
Name: prevalence, dtype: int64
================
column 34: disease_mechanism
loss of function                                                                                                                                                                          29253
gain of function                                                                                                                                                                           1936
Disease mechanisms vary by gene.                                                                                                                                                            854
gain of function;loss of function                                                                                                                                                           199
Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function                                       190
loss of function;gain of function                                                                                                                                                           149
Affects gamma-sarcoglycan and also disrupts the integrity of the entire sarcoglycan complex.                                                                                                136
Other                                                                                                                                                                                       106
May be benign                                                                                                                                                                                63
unknown                                                                                                                                                                                      19
Disease mechanisms vary by gene.;loss of function                                                                                                                                             5
gain of function;Disease mechanisms vary by gene.                                                                                                                                             2
Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function;Disease mechanisms vary by gene.        1
Dominant Negative                                                                                                                                                                             1
Name: disease_mechanism, dtype: int64
================
column 35: origin
germline                                        256404
not provided                                      7618
unknown                                           6995
germline;unknown                                  5103
somatic                                           2495
germline;not provided                             2426
not provided;germline                             1026
de novo                                           1001
unknown;germline                                   851
inherited                                          540
maternal                                           344
germline;somatic                                   271
de novo;germline                                   253
germline;not provided;unknown                      250
not provided;unknown                               223
paternal                                           194
germline;inherited                                 187
germline;de novo                                   147
somatic;germline                                   133
germline;maternal                                  109
germline;paternal                                  100
germline;unknown;not provided                       51
not applicable                                      50
not provided;germline;unknown                       49
germline;maternal;unknown                           41
inherited;germline                                  41
not provided;unknown;germline                       36
de novo;unknown                                     32
de novo;germline;unknown                            30
germline;not applicable                             28
                                                 ...  
unknown;germline;not provided                        1
germline;de novo;inherited                           1
germline;maternal;unknown;not provided               1
not provided;germline;unknown;maternal               1
somatic;germline;maternal;paternal                   1
de novo;not provided;unknown                         1
not provided;de novo;germline;unknown                1
de novo;not provided                                 1
not-reported                                         1
germline;paternal;unknown;de novo                    1
germline;somatic;not provided;unknown                1
not provided;inherited;germline                      1
unknown;germline;de novo                             1
germline;somatic;paternal;unknown                    1
somatic;germline;not provided;unknown                1
unknown;maternal                                     1
unknown;germline;de novo;somatic                     1
germline;somatic;de novo                             1
germline;not provided;biparental                     1
germline;not applicable;not provided;unknown         1
germline;unknown;maternal;de novo;inherited          1
germline;de novo;unknown;somatic                     1
germline;not applicable;somatic                      1
inherited;maternal;not provided                      1
not provided;germline;de novo                        1
maternal;not provided;unknown                        1
not provided;paternal;germline                       1
germline;unknown;inherited                           1
germline;unknown;de novo;maternal                    1
germline;not provided;unknown;inherited              1
Name: origin, dtype: int64
